WO2010090502A3 - External use composition containing cholecalciferol or its derivative for treating skin disorders - Google Patents

External use composition containing cholecalciferol or its derivative for treating skin disorders Download PDF

Info

Publication number
WO2010090502A3
WO2010090502A3 PCT/KR2010/000808 KR2010000808W WO2010090502A3 WO 2010090502 A3 WO2010090502 A3 WO 2010090502A3 KR 2010000808 W KR2010000808 W KR 2010000808W WO 2010090502 A3 WO2010090502 A3 WO 2010090502A3
Authority
WO
WIPO (PCT)
Prior art keywords
derivative
skin disorders
treating skin
composition containing
external use
Prior art date
Application number
PCT/KR2010/000808
Other languages
French (fr)
Korean (ko)
Other versions
WO2010090502A2 (en
Inventor
김성욱
전성수
구자성
김진욱
Original Assignee
한올바이오파마주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 한올바이오파마주식회사 filed Critical 한올바이오파마주식회사
Publication of WO2010090502A2 publication Critical patent/WO2010090502A2/en
Publication of WO2010090502A3 publication Critical patent/WO2010090502A3/en

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82B—NANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
    • B82B3/00—Manufacture or treatment of nanostructures by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
    • H01L21/00—Processes or apparatus adapted for the manufacture or treatment of semiconductor or solid state devices or of parts thereof
    • H01L21/02—Manufacture or treatment of semiconductor devices or of parts thereof
    • H01L21/04—Manufacture or treatment of semiconductor devices or of parts thereof the devices having potential barriers, e.g. a PN junction, depletion layer or carrier concentration layer
    • H01L21/18—Manufacture or treatment of semiconductor devices or of parts thereof the devices having potential barriers, e.g. a PN junction, depletion layer or carrier concentration layer the devices having semiconductor bodies comprising elements of Group IV of the Periodic Table or AIIIBV compounds with or without impurities, e.g. doping materials
    • H01L21/20—Deposition of semiconductor materials on a substrate, e.g. epitaxial growth solid phase epitaxy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Manufacturing & Machinery (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Physics & Mathematics (AREA)
  • Computer Hardware Design (AREA)
  • Microelectronics & Electronic Packaging (AREA)
  • Power Engineering (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

The prevent invention relates to an external use composition containing cholecalciferol or a derivative thereof for treating skin disorders. More specifically, the present invention relates to an external preparation composition for treating skin disorders such as atopic dermatitis and a method for manufacturing a liposome. The composition and method increase skin penetration by enclosing cholecalciferol (vitamin D3) or a derivative thereof as an active ingredient in a nanoscopic liposome so that skin penetration time can be minimized when applied to a lesion. Therefore, variations in drug effects due to light are reduced and drug effects are quickly expressed.
PCT/KR2010/000808 2009-02-09 2010-02-09 External use composition containing cholecalciferol or its derivative for treating skin disorders WO2010090502A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2009-0010324 2009-02-09
KR1020090010324A KR101147600B1 (en) 2009-02-09 2009-02-09 Topical formulations for treating skin diseases containing cholecalciferol or their derivatives

Publications (2)

Publication Number Publication Date
WO2010090502A2 WO2010090502A2 (en) 2010-08-12
WO2010090502A3 true WO2010090502A3 (en) 2011-01-20

Family

ID=42542544

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2010/000808 WO2010090502A2 (en) 2009-02-09 2010-02-09 External use composition containing cholecalciferol or its derivative for treating skin disorders

Country Status (2)

Country Link
KR (1) KR101147600B1 (en)
WO (1) WO2010090502A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111494321A (en) * 2020-04-28 2020-08-07 南通华山药业有限公司 Calcitriol long-circulating liposome and preparation method thereof
IT202200000629A1 (en) * 2022-01-17 2023-07-17 Fondazione St Italiano Tecnologia VITAMIN NANOCLUSTERS AS CARRIERS AND THERAPEUTIC AND NUTRACEUTICAL AGENTS

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5834016A (en) * 1996-04-04 1998-11-10 Cilag Ag Liposome-based topical vitamin D formulation
EP0998925A1 (en) * 1997-05-26 2000-05-10 New Vision Co., Ltd. Medicinal compositions for topical administration containing vitamin d and vitamin k
US20050026877A1 (en) * 2002-12-03 2005-02-03 Novacea, Inc. Pharmaceutical compositions comprising active vitamin D compounds
US20070110685A1 (en) * 2005-06-17 2007-05-17 Auspitz Benjamin A Combination therapy for the treatment of immunoinflammatory disorders
US20080280860A1 (en) * 2005-03-23 2008-11-13 Bioxell S.P.A. Use of Vitamin D Compounds to Treat Endometriosis

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5834016A (en) * 1996-04-04 1998-11-10 Cilag Ag Liposome-based topical vitamin D formulation
EP0998925A1 (en) * 1997-05-26 2000-05-10 New Vision Co., Ltd. Medicinal compositions for topical administration containing vitamin d and vitamin k
US20050026877A1 (en) * 2002-12-03 2005-02-03 Novacea, Inc. Pharmaceutical compositions comprising active vitamin D compounds
US20080280860A1 (en) * 2005-03-23 2008-11-13 Bioxell S.P.A. Use of Vitamin D Compounds to Treat Endometriosis
US20070110685A1 (en) * 2005-06-17 2007-05-17 Auspitz Benjamin A Combination therapy for the treatment of immunoinflammatory disorders

Also Published As

Publication number Publication date
KR20100091048A (en) 2010-08-18
KR101147600B1 (en) 2012-05-21
WO2010090502A2 (en) 2010-08-12

Similar Documents

Publication Publication Date Title
WO2014188276A3 (en) Antioxidant compositions and methods of using the same
WO2009047644A3 (en) Method of treating vitamin d insufficiency and deficiency
WO2010000877A3 (en) Formulation with irritation reducing action comprising bisabolol and [6]-paradol
WO2014138471A3 (en) Resorcinol compounds for dermatological use
WO2009147402A3 (en) Compositions comprising honey and a super- absorbent material
WO2006120682A3 (en) Compositions and methods for treating hyperproliferative epidermal diseases
WO2008048963A3 (en) Natural compositions for killing parasites on a companion animal
AU2014359194A1 (en) Lipid microcapsules preferably comprising a retinoid, and composition containing same, method for the production thereof, and use thereof in dermatology
WO2010027792A8 (en) Treatment of sweating and hyperhidrosis
WO2011130302A3 (en) Method of treating obesity using antioxidant inflammation modulators
WO2009105294A3 (en) Topical compositions and methods for whitening skin
WO2007096601A3 (en) Antimicrobial formulations comprising a quinone and a copper salt
HK1150027A1 (en) Preparation for preventing or ameliorating wrinkles, to be taken orally, through injection, or through external application to skin, and cosmetic method
WO2011090270A3 (en) Composition containing osmotin for preventing and treating neurological disorders
WO2006120681A3 (en) Compositions and methods for skin care
WO2013178965A3 (en) Active ingredients activating mitophagy in skin cells and use of same for improving skin condition
EP3067059A4 (en) Pharmaceutical composition for preventing or treating thyroid diseases, containing lonicera caerulea l. var. edulis fruit extract as active ingredient
WO2011042902A3 (en) Microcapsules comprising benzoyl peroxide and topical compositions comprising them
WO2011049327A3 (en) A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof
EP3034082A4 (en) Pharmaceutical composition for treating or preventing neuropsychitric disease, containing flavone-6-c-glucose derivatives as active ingredients
WO2012050745A3 (en) Compositions containing zinc pca and anogeissus extract
WO2009118726A3 (en) Oral combination of vitamins
WO2012002730A3 (en) Skin-whitening and skin-moisturizing composition containing bee venom extracts
IN2014DE01913A (en)
WO2005004891A3 (en) Use of an antioxidant in a dermatological and/or cosmetic composition

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10738786

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10738786

Country of ref document: EP

Kind code of ref document: A2